We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Saturday
May 16
09:30 - 10:15
Poster Area
Lower GI malignancies
Poster Highlights
Clinical
Comparison of Total Neoadjuvant Therapy Using Short? vs Long?Course Radiotherapy in Locally Advanced Rectal Cancer: Interim Results of TEHRAN study
Reza Ghalehtaki, Iran Islamic Republic of
-454
Advanced anal cancer: real-world patient, tumour and treatment characteristics
Renee Lunenberg, The Netherlands
-2265
Long-Term Oncologic and Patient-Reported Outcomes After IMRT-Based Chemoradiotherapy for Anal Canal Cancer: The PROACT Study.
stefania manfrida, Italy
-3106
Short course radiotherapy with dose escalation improves tumour response
Tomasz Wiśniewski, Poland
-3428
Tailored radiotherapy strategies for early stage rectal cancer: 10-year follow-up of a de-escalation prospective study
Gabriele D'Ercole, Italy
-3456
Acute Side Effects of Short-Course Radiotherapy in Rectal Cancer
Nagendran Balaramal, Malaysia
-3494
Curative chemoradiotherapy and watch-and-wait management in patients with rectal cancer  treated outside a clinical trial setting
Birgitte Havelund, Denmark
-558
Assessing dosimetric benefit of reduced prophylactic volumes in chemoradiotherapy in early anal squamous cell carcinoma – using data from PLATO-ACT4
Rebecca Muirhead, United Kingdom
-4034
THUNDER-2 an escalating radiation therapy dose trial in non-responder patients affected by rectal cancer: an interim quality of life (QoL) analysis
Isabella Costamagna, Italy
-4147
The Neoadjuvant Rectal (NAR) Score as a Predictor of Early Metastatic Risk in Locally Advanced Rectal Cancer (LARC) patients treated with TNT
Iwona Dębosz-Suwińska, Poland
-4294
Quality of life after colorectal cancer treatment within the CITRuS1 study
Alex Stewart, United Kingdom
-4443
Safety and efficacy of ketogenic diet and supplementation during chemoradiotherapy in rectal cancer:A prospective clinical trial(IRCT20170211032494N4)
Nima Mousavi Darzikolaee, Iran Islamic Republic of
-4572
Total Neoadjuvant Therapy Using VMAT?SIB With Consolidation Chemotherapy Improves Complete Response in Low?Lying Rectal Cancer
Mohammad Babaei, Iran Islamic Republic of
-638
Impact of Total Neoadjuvant Therapy versus Conventional Chemoradiotherapy on Quality of Life in Rectal Cancer: Systematic Review and Meta-Analysis
Syadwa Abdul Shukor, Malaysia
-772
Prognostic role of sarcopenia in anal squamous cell carcinoma treated with chemoradiotherapy: systematic review and meta-analysis
Joanna Socha, Poland
-931
Neoadjuvant RTQT Combined with Locoregional Hyperthermia in LARC: Feasibility and Tolerance of Short-Course Versus Long-Course Radiotherapy Schedules
Barbara Gabriela Salas Salas, Spain
-1047
Decision regret in patients with rectal cancer undergoing radiotherapy
Tim Werfel, Germany
-1135
Sex-specific differences in outcomes and toxicity after total neoadjuvant therapy for locally advanced rectal cancer
Maike Trommer, Germany
-1786
Comparison of Total Neoadjuvant Therapy with or without PD-1 blockade ?iTNT vs TNT?for Locally Advanced Rectal Cancer
Fan Xia, China
-1821